SELLAS Life Sciences Group, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2010 | -493.5% | -493.5% | -160.4% |
| FY2011 | -113.6% | -113.6% | -37.1% |
| FY2012 | -126.0% | -126.0% | -63.6% |
| FY2013 | -1,302.7% | -562.6% | -87.2% |
| FY2014 | -98.8% | -88.1% | -45.5% |
| FY2015 | 521.1% | 521.1% | -77.8% |
| FY2016 | 353.8% | 353.8% | -275.4% |
| FY2017 | -1,147.5% | -507.5% | -70.9% |
| FY2018 | -527.6% | -527.6% | -163.6% |
| FY2019 | -316.6% | -316.6% | -116.2% |
| FY2020 | -59.9% | -59.9% | -36.4% |
| FY2021 | -101.7% | -101.7% | -78.8% |
| FY2022 | -851.4% | -851.4% | -197.2% |
| FY2023 | 468.2% | 468.2% | -600.4% |
| FY2024 | -326.3% | -326.3% | -158.9% |
| FY2025 | -37.9% | -37.9% | -34.3% |